COEP — Coeptis Therapeutics Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- $10.62m
- $11.92m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.002 | -17.3 | 15.2 | -37.6 | -21.3 |
Depreciation | |||||
Non-Cash Items | — | 17.2 | -15.9 | 33.2 | 11.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0 | -0.047 | 0.178 | -0.55 | 1.8 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -0.002 | -0.116 | -0.503 | -3.88 | -7.24 |
Other Investing Cash Flow Items | — | -75.8 | — | 0 | 0 |
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | -75.8 | — | 0 | 0 |
Financing Cash Flow Items | -0.088 | -0.325 | 0 | -0.615 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.002 | 76.8 | 0 | 5.49 | 4.92 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.001 | 0.907 | -0.503 | 1.61 | -2.32 |